Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-06-29

FDA Approved: CLOMIPRAMINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for clomipramine hydrochloride (Sun Pharmaceutical Industries), a drug used to treat obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOMIPRAMINE HYDROCHLORIDE (clomipramine hydrochloride)

Snippet

SUPPL AP for CLOMIPRAMINE HYDROCHLORIDE (CLOMIPRAMINE HYDROCHLORIDE)